Sofinnova Ventures »

iShares NASDAQ Biotechnology Index shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2025-09-30 $47M 325k 144.37
2025-06-30 $47M 375k 126.51

More positions owned by Sofinnova Ventures

Natera (NTRA)
Gilead Sciences (GILD)
United Therapeutics Corporation Put Option (UTHR)
Vera Therapeutics Cl A (VERA)
Jazz Pharmaceuticals Shs Usd (JAZZ)
AstraZeneca Sponsored Adr (AZN)
Rapport Therapeutics (RAPP)
Boston Scientific Corporation (BSX)
Uniqure NV SHS Call Option (QURE)
Dex (DXCM)
Intuitive Surgical (ISRG)
Axsome Therapeutics (AXSM)
Roivant Sciences SHS (ROIV)
iShares TR Ishares Biotech Put Option (IBB)
Vertex Pharmaceuticals Incorporated (VRTX)

View all positions for Sofinnova Ventures

Top funds holding iShares NASDAQ Biotechnology Index

Morgan Stanley
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
UBS Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Commerce Bank N A
Wells Fargo & Company
Royal Bank of Canada
Calamos Advisors
Jane Street
Citadel Advisors
Leucadia National Corporation
Barclays

View all funds holding iShares NASDAQ Biotechnology Index